Search This Blog

Thursday, April 17, 2025

Hikma acquires rights to generic version of Novartis' Mekinist

 Trametinib is an orally administered kinase inhibitor used in the treatment of certain cancers. It is the generic version of Mekinist

https://seekingalpha.com/news/4432336-hikma-acquires-rights-to-generic-version-of-novartis-mekinist

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.